Aims To examine the association between colour vision deficiency (CVD) and other ophthalmic disorders including amblyopia, strabismus and ametropia in a large population study. Methods The ...

This marks a pivotal milestone in the transformation of pediatric vision care, significantly expanding access to effective ...

FDA-cleared CureSight™ therapy now reimbursed by Elevance Health, expanding access to effective digital treatment for lazy ...

Luminopia, Inc., a digital health company pioneering a new class of treatments for neuro-visual disorders, today announced that the U.S. Food & Drug Administration (FDA) cleared its amblyopia ...

Luminopia One can now be prescribed to improve visual acuity in children aged 4-7 with amblyopia associated with mild strabismus – or crossed eyes – and/or a condition called anisometropia ...

The largest amblyopia treatment registry to-date, the PUPiL Registry uses an all-comers' design to evaluate real-world outcomes in a representative population. It's comprised of more than 500 ...

00145 - Digital Therapy Devices for Treatment of Amblyopia), which now recognizes ... American Association for Pediatric Ophthalmology and Strabismus (AAPOS) played a critical role in achieving ...